Product News
Diasorin Announces 510(K) Clearance for LIAISON PLEX® Gram-Positive Blood Culture Assay
Diasorin’s LIAISON PLEX® Gram-Positive Blood Culture Assay receives FDA clearance, aiding rapid, targeted infection diagnosis.
Product News
Thermo Fisher Scientific Unveils Next-Generation Mass Spectrometers at ASMS 2025
Thermo Fisher launches the Orbitrap Astral Zoom and Orbitrap Excedion Pro MS at ASMS 2025, advancing proteomics and drug development.
Product News
Thermo Fisher Scientific Launches Cutting-Edge Solutions for Omics, Biopharma and Environmental Workflows at ASMS 2025
Thermo Fisher introduces next-gen mass spectrometry solutions at ASMS, designed to accelerate research in multiple scientific fields.
Product News
SCIEX and Evosep Expand Access to Standardized Proteomics for Pharma and Biotech With New Reseller Agreement
SCIEX and Evosep announce a reseller agreement to co-sell mass spectrometry systems and Evosep Eno for high-throughput proteomics.
Product News
Antibodies for Stem Cell Quality Validation
Amsbio expands antibody portfolio with new markers for precise stem cell research and quality assurance.
Product News
Seer Redefining Deep Unbiased Proteomics With Launch of New Proteograph Workflow at ASMS 2025
Seer launches Proteograph ONE, doubling throughput and cutting costs for deep, scalable proteomics.
Product News
New Study Shows Impact of Ambry Genetics’ Patient for Life™ Program on Rare Disease Diagnosis
Ambry Genetics’ Patient for Life™ program helps provide diagnoses for rare diseases by reanalyzing exome sequencing data, offering hope to patients with undiagnosed conditions.
Product News
Thermo Fisher Scientific Introduces Next Generation TruNarc Handheld Narcotics Analyzers To Support Public Safety Share
Thermo Fisher’s TruNarc Delta and Tau analyzers enhance law enforcement’s ability to identify over 1,200 narcotics quickly and accurately, even in the field.
Product News
Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing
Revvity launches the IDS i20™ platform, automating chemiluminescence immunoassays for multiple diagnostic specialties, increasing throughput and flexibility.
Product News
Optimer Licensing Agreements and Repeat Custom
Aptamer Group has secured two new development contracts and a licensing agreement to expand its Optimer platform’s applications in enzyme modulation and small molecule recognition.
Advertisement